What type of study is this?

This is a Human Clinical Trial study.

September 20, 2025Tạp chí Da liễu học Việt NamOpen Access

Efficacy and Safety of Guselkumab in the Treatment of Plaque Psoriasis

View Full Paper

Ask AI

Bookmark

Authors

LDLoan DangVietnam National University Ho Chi Minh City LTLinh T. TrinhVanderbilt University VNVincent NguyenKansas City University

Discussion

Member takes

Implication

Clinical trial evaluates guselkumab's high efficacy and safety in moderate to severe plaque psoriasis, suggesting it may be a suitable treatment option.

Key Points

Guselkumab treatment resulted in a significant reduction in PASI and DLQI scores after 20 weeks.
PASI75 and PASI90 response rates reached 93.8% and 71.9% at week 20, indicating high efficacy.
The clinical trial involved 32 patients receiving guselkumab injections and reporting no adverse events.
Findings highlight guselkumab's potential as an effective treatment for plaque psoriasis with minimal side effects.

Cite This Study

Dang et al. (2025) studied this question.

synapsesocial.com/papers/68d46aae31b076d99fa67960 https://doi.org/10.56320/tcdlhvn.49.258

View Full Paper

Ask AI

Bookmark

Implication

Clinical trial evaluates guselkumab's high efficacy and safety in moderate to severe plaque psoriasis, suggesting it may be a suitable treatment option.

Efficacy and Safety of Guselkumab in the Treatment of Plaque Psoriasis

Discussion

Member takes

Implication

Key Points

Cite This Study

Efficacy and Safety of Guselkumab in the Treatment of Plaque Psoriasis

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider